Enifer, a Finnish biotech company, has achieved self-affirmed GRAS status for its mycoprotein ingredient PEKILO®, marking a crucial milestone in the regulatory process for full FDA approval. This dry, powdered mycoprotein offers shelf stability, cost efficiency, and easy integration into production lines, making it an attractive option for plant-based foods, sports nutrition, and healthy snacks. Enifer's CEO highlighted PEKILO®'s unique properties, emphasizing its potential to enhance texture, nutrition, and consumer appeal in plant-based products.

Enifer, founded in 2020, utilizes fermentation technology to convert byproducts into high-quality protein and has raised €36 million to expand its production capabilities. The company is working on securing notified GRAS status for PEKILO® to further reassure US food manufacturers and facilitate market acceptance. Enifer is eager to collaborate with US food manufacturers to introduce their mycoprotein ingredient that delivers high levels of protein and fiber for innovative food applications.